BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11912548)

  • 1. Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population.
    Tinahones FJ; Gómez-Zumaquero JM; Rojo-Martínez G; Cardona F; Esteva de Antonio IE; Ruiz de Adana MS; Soriguer FJ
    Metabolism; 2002 Apr; 51(4):429-31. PubMed ID: 11912548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.
    Lehtimäki T; Lehtinen S; Solakivi T; Nikkilä M; Jaakkola O; Jokela H; Ylä-Herttuala S; Luoma JS; Koivula T; Nikkari T
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):23-7. PubMed ID: 9888862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population.
    Tinahones FJ; Gómez-Zumaquero JM; Garrido-Sánchez L; García-Fuentes E; Rojo-Martínez G; Esteva I; Ruiz de Adana MS; Cardona F; Soriguer F
    J Lipid Res; 2005 Mar; 46(3):452-7. PubMed ID: 15604526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
    Turk Z; Mrzljak V; Turk N; Metelko Z
    Diabetes Nutr Metab; 1999 Dec; 12(6):413-7. PubMed ID: 10782563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-oxidized LDL antibody levels are reduced in women with hypertension.
    Garrido-Sánchez L; García-Fuentes E; Cardona F; Rojo-Martínez G; Soriguer F; Tinahones FJ
    Eur J Clin Invest; 2009 Sep; 39(9):800-6. PubMed ID: 19674079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease.
    Orem A; Cimşit G; Değer O; Vanizor B; Karahan SC
    Dermatology; 1999; 198(3):243-6. PubMed ID: 10393445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auto antibodies against oxidized low density lipoprotein in severe preeclampsia.
    Jain M; Sawhney H; Aggarwal N; Vashistha K; Majumdhar S
    J Obstet Gynaecol Res; 2004 Jun; 30(3):188-92. PubMed ID: 15210040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
    Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
    Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized fatty acids promote atherosclerosis only in the presence of dietary cholesterol in low-density lipoprotein receptor knockout mice.
    Khan-Merchant N; Penumetcha M; Meilhac O; Parthasarathy S
    J Nutr; 2002 Nov; 132(11):3256-62. PubMed ID: 12421837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a).
    Silaste ML; Rantala M; Alfthan G; Aro A; Witztum JL; Kesäniemi YA; Hörkkö S
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):498-503. PubMed ID: 14739118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
    Radulescu L; Stancu C; Antohe F
    Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized low-density lipoprotein autoantibodies in patients with primary gout: effect of urate-lowering therapy.
    Tsutsumi Z; Moriwaki Y; Takahashi S; Ka T; Yamamoto T
    Clin Chim Acta; 2004 Jan; 339(1-2):117-22. PubMed ID: 14687901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of metabolic control on oxidized low-density lipoprotein antibodies in children and adolescents with type 1 diabetes mellitus.
    Kara C; Cetinkaya S; Sezgin N; Kinik ST
    Pediatr Diabetes; 2008 Feb; 9(1):17-22. PubMed ID: 18211632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients.
    Bednarska-Makaruk M; Rodo M; Graban A; Lojkowska W; Bochyńska A; Ryglewicz D; Wehr H
    J Neurol Sci; 2009 Aug; 283(1-2):137-8. PubMed ID: 19303604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ezetimibe on remnant-like particle cholesterol, lipoprotein (a), and oxidized low-density lipoprotein in patients with dyslipidemia.
    Nozue T; Michishita I; Mizuguchi I
    J Atheroscler Thromb; 2010 Feb; 17(1):37-44. PubMed ID: 20075599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL.
    Bergmark C; Wu R; de Faire U; Lefvert AK; Swedenborg J
    Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):441-5. PubMed ID: 7749854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.